General
Bayer's Quarterly Analysis Reports Problems With Essure
On Monday, Bayer, the manufacturer of the controversial birth control device, Essure, issued the…
Nine PPI Drugs Bellwether Cases Selected For Discovery
On December 4, U.S. District Judge Claire C. Cecchi, overseeing the proton pump inhibitor (PPI) drugs litigation, issued a case management order (CMO)…
First Bard Hernia Mesh Bellwether Jury Trial Rescheduled To April 2021
The first bellwether jury trial of Bard hernia mesh lawsuit has been rescheduled to begin on April 19, 2021, by the U.S. District Judge considering the ongoing pandemic.
…
3 Years Of Probation For Ex-Insys Manager Over Opioid Crisis
On Wednesday, U.S. District Judge Janet Bond Arterton in Hartford, Connecticut, at a hearing held via videoconference, sentenced a former Insys Therapeutics Inc. sales manager to three years of probation for his role in paying doctors kickbacks…
Teva Moves A ParaGard IUD Lawsuit To Federal Court System
Earlier this week, Teva Pharmaceuticals filed a notice over the removal of a ParaGard IUD lawsuit to the Eastern District of Pennsylvania, which was originally filed in the Philadelphia County Court of Common Pleas.
The lawsuit was filed by…
J&J's Appeal Over $325M Asbestos Talc Verdict Rejected
On November 12, a stipulation was filed in the New York Supreme Court for New York County, indicating that the court has rejected Johnson & Johnson’s (J&J) challenge over a $325 million…
Plavix Plus Aspirin Linked To Bleeding Risk In TAVI Patients
On October 8, a study was published in the New England Journal of Medicine where the researchers from the Netherlands indicated that patients with a…
W.Va. Opioid Trial Postponed To 2021 Amidst COVID-19 Crisis
A federal judge of West Virginia has rescheduled the trial of the nation's largest drug distributors over their role in the opioid epidemic. The trial, originally scheduled…
Mallinckrodt To End Opioid Epidemic With $1.6B Settlement
Mallinckrodt Pharmaceuticals, the Irish–based manufacturer of generic drugs, agreed to pay $1.6 billion to resolve the mounting lawsuits that claim the manufacturer of fueling the opioid…